We had analyzed the overexpression and poor prognostic value of YWHAZ, BRCA1, and YWHAG in BRCA, so can we reasonably speculate on developing a drug to inhibit YWHAZ, BRCA1, and YWHAG-related functions to suppress cancer progression and make patients have a good prognosis. The gene discussed is BRCA1; the disease is cancer.